Meridian Clinical Research,

Omaha, Nebraska 68164

0 studies enrolling now · 50 studies all time

What they study most

Acne Vulgaris, Anthrax, Atopic Dermatitis, COVID-19, COVID-19 Disease, Chikungunya Virus Infection, Chronic Lung Disease, Chronic Pain, Fibromyalgia, Gastroesophageal Reflux Disease, Healthy, Hot Flashes

Studies at this site

• Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine — Completed
• Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in Adults — Completed
• Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOS — Running, not enrolling
• Ciprofloxacin BioThrax Co-Administration Study — Completed
• ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2 — Completed
• Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults — Completed
• Safety, Tolerability and Pharmacokinetics of TPOXX When Administered Orally for 28 Days — Completed
• Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Older Adults — Completed
• A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19 — Completed
• A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults — Completed
• Study to Demonstrate Consistency of Three Lots of a Live-attenuated Chikungunya Virus Vaccine Candidate in Healthy Adults — Completed
• Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seronegative Children 6-36 Months — Status unconfirmed
• Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok — Completed
• Phase 2 Study of TD-9855 to Treat Fibromyalgia — Completed
• Study to Evaluate the Safety and Immunogenicity of KBP-V001 Quadrivalent Influenza Vaccine in Healthy Adults — Completed
• Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis — Completed
• Study of Glycopyrronium in Axillary Hyperhydrosis — Completed
• A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris — Completed
• A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris — Completed
• Study of the Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seropositive Children — Completed
• Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) — Completed
• A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome — Completed
• A STUDY OF A RSV VACCINE WHEN GIVEN TOGETHER WITH TDAP IN HEALTHY NONPREGNANT WOMEN AGED BETWEEN 18 TO 49 YEARS — Completed
• An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine — Completed
• Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris — Completed
• An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine — Completed
• Safety and Immunogenicity of Two Trivalent Subunit Influenza Vaccines in Healthy Adult Subjects — Completed
• A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Dermatitis — Completed
• Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents — Completed
• Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis) — Completed
• Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin — Completed
• Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age — Completed
• Trial to Evaluate the Immunogenicity and Safety of Panblok® (H7 rHA) in Healthy Adults Aged 18 and Older — Completed
• Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) in Patients Who Require Opioid Treatment for an Extended Period of Time — Completed
• Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) for Relief of Moderate to Severe Pain in Patients With Osteoarthritis or Low Back Pain Who Require Opioid Treatment for an Extended Period of Time — Completed
• Safety and Immunogenicity of Flublok Quadrivalent vs IIV4 in Adults 18-49 Years of Age — Completed
• Quadrivalent Influenza VLP Vaccine Dose Ranging Study in Young Adults — Completed
• A Multicenter Study of Pseudoephedrine for the Temporary Relief of Nasal Congestion in Children With the Common Cold — Completed
• A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years. — Completed
• Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults — Completed
• Study of Meloxicam Capsules to Treat Osteoarthritis Pain — Completed
• Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age — Completed
• Study of Diclofenac Capsules to Treat Osteoarthritis Pain — Completed
• Open-Label Study of Diclofenac Capsules to Treat Osteoarthritis Pain — Completed
• A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis (SHaRCS) — Completed
• Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults — Completed
• Estradiol Transdermal Spray in the Treatment of Vasomotor Symptoms — Completed
• A Study to Evaluate the Safety of HIN1 Monovalent Vaccine (MEDI3414) in Children 2 to 17 Years of Age — Completed
• Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder — Completed
• Study of the Protective Effect of an Injectable Influenza Vaccine Against Influenza Illness in Adults Under 50 y.o. — Status unconfirmed